<b>Conclusion:</b> Our data reveal the PFKM-p53-PD-1 axis that suppresses macrophage phagocytosis in sepsis and highlight the therapeutic potential of targeting this pathway with nanobody-based strategies. This evidence concerns the gene TP53 and Sepsis.